Comparison of Absorption of Budesonide and Formoterol From Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler

Launched by ORION CORPORATION, ORION PHARMA · May 4, 2012

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Healthy males and females aged 18-60 years.
• • 2. Normal weight, at least 50 kg.
• Exclusion Criteria:
• • 1. Evidence of a clinically significant cardiovascular, renal, hepatic, haematological, GI, pulmonary, metabolic-endocrine, neurological or psychiatric disease.
• • 2. Any clinically significant abnormal laboratory value or physical finding that may interfere with the interpretation of study results or constitute a health risk for the subject if he/she takes part in the study.
• • 3. Any condition requiring regular concomitant treatment (including vitamins and herbal products) or likely to need any concomitant treatment during the study.
• • 4. Known hypersensitivity to the active substance(s) or the excipient of the drug.
• • 5. Pregnant or lactating females.